OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. Various strategies are employed enhance antibody titer, comprising process parameter optimization, cell line development, and the use of perfusion processes. Fine-tuning culture conditions